Skip to content

13F-HR filed by AJU IB Investment Co., Ltd.

AJU IB Investment Co., Ltd. filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-05-12, with 11 holding rows worth $265,104,000.

Accession
0001567619-21-009612
Filed
2021-05-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2021

A holdings report, 11 entries on the cover page, a total value of $265,104,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $265,104,000 with VALUE read as thousands by filing date, 13F file number 028-21185. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ATEA PHARMACEUTICALS INC04683R106COMMON STOCK2,049,331$126,546,000thousands by filing date
SEER INC81578P106COM CL A1,066,375$53,340,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM1,114,962$47,843,000thousands by filing date
KYMERA THERAPEUTICS INC501575104COM639,059$24,834,000thousands by filing date
SUTRO BIOPHARMA INC869367102COM175,000$3,983,000thousands by filing date
MOLECULAR TEMPLATES INC608550109COM204,809$2,585,000thousands by filing date
RAPT THERAPEUTICS INC75382E109COM108,503$2,409,000thousands by filing date
CLEARSIDE BIOMEDICAL INC185063104COM793,555$1,960,000thousands by filing date
KEZAR LIFE SCIENCES INC49372L100COM128,916$768,000thousands by filing date
AILERON THERAPEUTICS INC COM NEW00887A105Stock517,558$740,000thousands by filing date
BELLICUM PHARMACEUTICALS INC COM NEW079481404Stock25,651$96,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001567619-21-009612this filing2021-05-12acceptance time not in the bulk data set